PL336273A1 - Pharmaceutic composition active in stomach portion of gastrointestinal system - Google Patents
Pharmaceutic composition active in stomach portion of gastrointestinal systemInfo
- Publication number
- PL336273A1 PL336273A1 PL98336273A PL33627398A PL336273A1 PL 336273 A1 PL336273 A1 PL 336273A1 PL 98336273 A PL98336273 A PL 98336273A PL 33627398 A PL33627398 A PL 33627398A PL 336273 A1 PL336273 A1 PL 336273A1
- Authority
- PL
- Poland
- Prior art keywords
- gastrointestinal system
- composition active
- stomach portion
- pharmaceutic composition
- pharmaceutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704803A FR2762213B1 (en) | 1997-04-18 | 1997-04-18 | PHARMACEUTICAL COMPOSITION WITH GASTRIC RETENTION |
| PCT/FR1998/000755 WO1998047506A1 (en) | 1997-04-18 | 1998-04-15 | Gastric-retained pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL336273A1 true PL336273A1 (en) | 2000-06-19 |
Family
ID=9506077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98336273A PL336273A1 (en) | 1997-04-18 | 1998-04-15 | Pharmaceutic composition active in stomach portion of gastrointestinal system |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0983065A1 (en) |
| JP (1) | JP2001523241A (en) |
| KR (1) | KR20010006353A (en) |
| CN (1) | CN1252720A (en) |
| AR (1) | AR015586A1 (en) |
| AU (1) | AU737634B2 (en) |
| CA (1) | CA2286081A1 (en) |
| FR (1) | FR2762213B1 (en) |
| HU (1) | HUP0002455A3 (en) |
| IL (1) | IL131995A0 (en) |
| JO (1) | JO2017B1 (en) |
| MA (1) | MA26482A1 (en) |
| NO (1) | NO995039L (en) |
| NZ (1) | NZ500288A (en) |
| PE (1) | PE68199A1 (en) |
| PL (1) | PL336273A1 (en) |
| TN (1) | TNSN98049A1 (en) |
| WO (1) | WO1998047506A1 (en) |
| ZA (1) | ZA983258B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6169094B1 (en) * | 1998-07-14 | 2001-01-02 | Sanofi-Synthelabo | Compositions of (S) (-)-amisulpride |
| FR2784583B1 (en) | 1998-10-16 | 2002-01-25 | Synthelabo | PHARMACEUTICAL COMPOSITION WITH GASTRIC RESIDENCE AND CONTROLLED RELEASE |
| FR2790388B1 (en) * | 1999-03-04 | 2001-04-13 | Synthelabo | PHARMACEUTICAL COMPOSITIONS COMPRISING A BENZAMIDE AND AT LEAST ONE ABSORPTION PROMOTER |
| EP1245227A1 (en) | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
| WO2009157711A2 (en) * | 2008-06-24 | 2009-12-30 | Park Eun-Seok | Gastro-retentive porous tablet and method for preparing same |
| FR2949061B1 (en) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | FLOATING MICROGRANULES |
| HUE025008T2 (en) | 2012-10-12 | 2016-04-28 | Omya Int Ag | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
| CA3084953A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| MX2020005517A (en) | 2017-12-05 | 2020-11-09 | Sunovion Pharmaceuticals Inc | Crystal forms and production methods thereof. |
| JP7044649B2 (en) * | 2018-06-28 | 2022-03-30 | 株式会社ファンケル | Intragastric floating tablets |
| SG11202113266YA (en) | 2019-06-04 | 2021-12-30 | Sunovion Pharmaceuticals Inc | Modified release formulations and uses thereof |
| WO2023214018A1 (en) | 2022-05-06 | 2023-11-09 | Galenix Innovations | Gastro-retentive swellable sustained release composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2415099A1 (en) * | 1978-01-20 | 1979-08-17 | Ile De France | NEW DERIVATIVES OF 4-AMINO-5-ALKYLSULFONYL ORTHO-ANISAMIDES, THEIR METHODS OF PREPARATION AND THEIR APPLICATION AS PSYCHOTROPES |
| FR2554718B1 (en) * | 1983-11-14 | 1986-04-04 | Ethypharm Sa | NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE |
| FR2556964A1 (en) * | 1983-12-23 | 1985-06-28 | Ile De France | NEW GALENIC FORMS OF SULPIRIDE USED ORALALLY |
| JPS62178518A (en) * | 1986-01-30 | 1987-08-05 | Toho Yakuhin Kogyo Kk | Novel long-acting sulpiride tablet |
| JPH0776172B2 (en) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | Matrice locks |
| CA2039742A1 (en) * | 1990-04-23 | 1991-10-24 | Andrew B. Dennis | Tablet composition and method for problem pharmaceutical materials |
-
1997
- 1997-04-18 FR FR9704803A patent/FR2762213B1/en not_active Expired - Fee Related
-
1998
- 1998-04-15 NZ NZ500288A patent/NZ500288A/en unknown
- 1998-04-15 PL PL98336273A patent/PL336273A1/en unknown
- 1998-04-15 HU HU0002455A patent/HUP0002455A3/en unknown
- 1998-04-15 KR KR1019997009438A patent/KR20010006353A/en not_active Application Discontinuation
- 1998-04-15 CN CN98804269A patent/CN1252720A/en active Pending
- 1998-04-15 IL IL13199598A patent/IL131995A0/en unknown
- 1998-04-15 WO PCT/FR1998/000755 patent/WO1998047506A1/en not_active Application Discontinuation
- 1998-04-15 EP EP98920623A patent/EP0983065A1/en not_active Ceased
- 1998-04-15 JP JP54514398A patent/JP2001523241A/en active Pending
- 1998-04-15 AU AU73416/98A patent/AU737634B2/en not_active Ceased
- 1998-04-15 CA CA002286081A patent/CA2286081A1/en not_active Abandoned
- 1998-04-16 TN TNTNSN98049A patent/TNSN98049A1/en unknown
- 1998-04-17 PE PE1998000281A patent/PE68199A1/en not_active Application Discontinuation
- 1998-04-17 AR ARP980101773A patent/AR015586A1/en unknown
- 1998-04-17 MA MA25037A patent/MA26482A1/en unknown
- 1998-04-17 ZA ZA983258A patent/ZA983258B/en unknown
- 1998-04-18 JO JO19982017A patent/JO2017B1/en active
-
1999
- 1999-10-15 NO NO995039A patent/NO995039L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1252720A (en) | 2000-05-10 |
| IL131995A0 (en) | 2001-03-19 |
| CA2286081A1 (en) | 1998-10-29 |
| PE68199A1 (en) | 1999-07-15 |
| NO995039L (en) | 1999-12-17 |
| JP2001523241A (en) | 2001-11-20 |
| AU737634B2 (en) | 2001-08-23 |
| AR015586A1 (en) | 2001-05-16 |
| FR2762213B1 (en) | 1999-05-14 |
| FR2762213A1 (en) | 1998-10-23 |
| NZ500288A (en) | 2001-03-30 |
| JO2017B1 (en) | 1999-05-15 |
| TNSN98049A1 (en) | 2005-03-15 |
| AU7341698A (en) | 1998-11-13 |
| NO995039D0 (en) | 1999-10-15 |
| MA26482A1 (en) | 2004-12-20 |
| ZA983258B (en) | 1998-10-19 |
| WO1998047506A1 (en) | 1998-10-29 |
| HUP0002455A2 (en) | 2000-12-28 |
| HUP0002455A3 (en) | 2001-01-29 |
| KR20010006353A (en) | 2001-01-26 |
| EP0983065A1 (en) | 2000-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2332147B (en) | Therapeutically active compositions | |
| PL337237A1 (en) | Omeprazole pharmaceutic preparation | |
| HUP0003761A2 (en) | Substituted alkanohydroxamic acids and pharmaceutical compositions containing them | |
| HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
| GB9713149D0 (en) | Pharmaceutical formulations | |
| GB9706089D0 (en) | Pharmaceutical composition | |
| IL135177A0 (en) | Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same | |
| ZA982872B (en) | Pharmaceutical formulation | |
| HUP0002510A3 (en) | Tetrazole derivatives and pharmaceutical compositions containing them | |
| PL336273A1 (en) | Pharmaceutic composition active in stomach portion of gastrointestinal system | |
| PL344834A1 (en) | Pharmaceutical levothyroxine preparation | |
| IL142012A0 (en) | Stomach polypeptide zsig28 | |
| PL336982A1 (en) | Pharmaceutic compositions of peptides sparingly dissolvable in physiological media | |
| IL133928A0 (en) | Pharmaceutical composition containing peptichemio | |
| GB9717444D0 (en) | Pharmaceutical composition | |
| ZA982073B (en) | Pharmaceutical preparation | |
| GB9717428D0 (en) | Pharmaceutical composition | |
| PL336805A1 (en) | Pharmaceutic agents containing thysoxanide and intazoxanide | |
| IL187593A0 (en) | Gastrointestinal drug composition | |
| PL338856A1 (en) | Dried biologically or therapeutically active preparations | |
| GB9709739D0 (en) | Pharmaceutical formulation | |
| ZA982952B (en) | Pseudo-peptide compounds their preparation and use in pharmaceutical formulations | |
| GB9717770D0 (en) | Pharmaceutical composition | |
| HUP0004132A3 (en) | Rapidly soluble drug composition | |
| GB2321190B (en) | Pharmaceutical composition |